Skip to main content
. 2018 Aug 27;62(9):e00851-18. doi: 10.1128/AAC.00851-18

TABLE 4.

Prevalence of high-BLNAR isolates in Japan and other countries

Country Year(s) of isolation No. (%) of H. influenzae isolates
High-BLNAR strains among BLNAR strains (%) Reference
Total BLNARa High-BLNARb
Japan 2016–2018 104 62 (59.6) 57 (54.8) 91.9 This study
2011–2012 122 57 (46.7)c 52 (42.6) 91.2 22
2004–2005 172 61 (35.5)c 43 (25.0) 70.5 23
2003 264 172 (65.2)c 74 (28.0) 43.0 13
2002–2004 457 211 (46.2)c 121 (26.5) 57.3 42
2000–2009 508 247 (48.6)c 159 (31.3) 55.3 20
1999 296 78 (26.3)c 39 (13.1) 50.0 15
1995–2003 621 229 (36.9) 77 (12.4) 33.6 6
1987–2000 162 22 (13.6)c 3 (1.9) 13.6 19
Korea 2012 122 49 (40.2) 18 (14.8) 36.7 8
Norway 2007 808 116 (14.4) 3 (0.4) 2.6 14
Korea 2005–2006 540 33 (6.1) 8 (1.5) 33.3 21
Portugal 2001–2008 240 94 (39.1) 2 (0.8) 2.1 9
Spain 2001–2006 354 198 (55.9) 12 (3.4) 6.1 7
France 2000–2008 2,206 354 (16.0) 3 (0.14) 0.9 11
Spain 2000–2009 95 27 (28.4) 0 (0) 0 10
Korea 2000–2005 229 67 (29.3) 0 (0) 0 18
United States 1999 95 13 (13.7)c 0 (0) 0 15
a

Isolates with Arg517His or Asn526Lys substitutions in PBP3.

b

Isolates with Ser385Thr in addition to Arg517His or Asn526Lys substitutions in PBP3.

c

Defined by PCR.